Compounds > cilengitide
Page last updated: 2024-09-05

cilengitide and n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide

cilengitide has been researched along with n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide in 2 studies

Compound Research Comparison

Studies
(cilengitide)		Trials
(cilengitide)		Recent Studies (post-2010)
(cilengitide)		Studies
(n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide)		Trials
(n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide)		Recent Studies (post-2010) (n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide)
1942913318513

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tucker, GC1
Colombo, L; Paolillo, M; Russo, MA; Schinelli, S; Serra, M1

Reviews

2 review(s) available for cilengitide and n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide

ArticleYear
Integrins: molecular targets in cancer therapy.
    Current oncology reports, 2006, Volume: 8, Issue:2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biomarkers, Tumor; Central Nervous System Neoplasms; Clinical Trials as Topic; Glioblastoma; Humans; Indoles; Integrins; Melanoma; Neoplasms; Porphyrins; Skin Neoplasms; Snake Venoms; Sulfonamides

2006
Small molecule integrin antagonists in cancer therapy.
    Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:12

    Topics: Anoikis; Humans; Indoles; Integrin alphaVbeta3; Integrins; Neoplasms; Peptides; Receptors, Vitronectin; Signal Transduction; Snake Venoms; Sulfonamides

2009